Regulatory press releases

About CLS
IR
News & Media
Log in

Search for:

Terapi
- PrinciperSimplicity and precision
- ProcedurStimulates the immune system
- Kombinerade terapierStudies are planned
- Kliniska studierOngoing in Europe
- Horizon 2020EU-funded project
- IndikationerSolid tumors in different organs
- imILT – Scientific background
TRANBERG
- Mobile Laser UnitA unique system
- Thermoguide – soon to comeConcept of Thermoguide, soon to come
- Applikator kitFor a precise position
- CertifikatISO, EC, FDA
Publikationer
- Prekliniska studierThe research behind imILT®
- Kliniska studierStudies 1995–2015
- Posters
Kontakt
- KontaktHow to reach us
- SupportFill out the form
- FAQQuestions & answers

Search for:

Welcome to Clinical Laserthermia Systems.
Please choose a country or region.

Subscribe to our mailing list

Email Address

Regulatory press releases

Home / News & Media / Regulatory press releases

News & Media

All press releases
Regulatory press releases
Other press releases
Events
Newsletter
Video
Subscribe

WHERE TO FIND US
CLS head office is located next door to the Lund University Cancer Research Center at Medicon Village in Lund, Sweden.

CLS
Scheelegatan 2
223 81 Lund
Sweden

Phone: 046-15 21 00
E-mail: info@clinicallaser.se

Subscribe to our news!

Besök oss på LinkedIn.

About CLS
- Strategy
- Market
- Career
- History
- Privacy policy
IR
News & Media
Log in

Terapi
TRANBERG
Publikationer
Kontakt
- Kontakt
- Support
- FAQ

The TRANBERG®|Thermal Therapy System has not yet a market clearance for Immune stimulating interstitial laser thermotherapy (imILT®)
by the Food and Drug Administration (FDA) in the United States of America (USA)

(Svenska)

✕

Nyhetsbrev

Anmäl dig till vårt nyhetsbrev

We respect your privacy.